English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Treatment of the Burkitt lymphoma-derived cell line Daudi with highly purified human interferon-alpha (IFN-alpha) increased up to 100-fold the number of cells expressing Epstein-Barr virus (EBV)-determined early antigen (EA) without inducing the synthesis of virus capsid antigen (VCA), a late virus function. The increase in the number of EA-positive cells was proportional to interferon concentration up to 10(4) international units (IU)/ml. Treatment of Daudi cells with the same number of units of either partially purified (sp. act. 10(6) IU/mg protein) or electrophoretically pure (sp. act. 2 x 10(8) IU/mg protein) IFN-alpha both gave a similar increase in EA expression, strongly suggesting that the effects observed were indeed due to interferon. Furthermore, treatment of relatively interferon-insensitive Raji cells with IFN-alpha (1 to 10(4) IU/ml) had no significant effect on either spontaneous or 5-iodo-2'-deoxyuridine (IdUrd)-induced expression of EA or VCA. Human IFN-beta also enhanced the expression of EBV EA in Daudi cells. In contrast, when the latent EBV present in Daudi cells was activated to enter into a replicative cycle, either by induction with IdUrd or by superinfection with the non-transforming P3HR1 strain of EBV, then treatment with human IFN-alpha caused a marked inhibition of EA expression. Our results suggest that interferon can exert a differential action on virus replication depending upon the state of the virus genome within the cell.

Interferon Enhances the Expression of Epstein--Barr Virus Early Antigen in Daudi Cells